Brain Cancerfind mydrugscancerChemotherapy for Brain TumorsHigh Incidence of Secondary Brain Tumours After Radiotherapy and AntimetabolitesBrain and Other Central Nervous System Cancers: Recent Trends in Incidence and MortalityBrain Metastases in Patients with No Known Primary TumorLong-Term Outcomes after Radiosurgery for Acoustic NeuromasOutcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institutionSurvival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiformeStereotactic Radiosurgery in the Treatment of Metastatic Disease to the BrainWhole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialBrain metastases treated with radiosurgery alone: An alternative to whole brain radiotherapy?Randomized Trial on the efficacy of Radiotherapy for Cerebral Low-Grade Glioma in the Adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BR04: An Interim AnalysisThe risk of hemorrhage after radiosurgery for cerebral arteriovenous malformationsRadiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaPrognostic Value of Initial Magnetic Resonance Imaging Growth Rates for World Health Organization Grade II Glioma
Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
Randomized Trial on the efficacy of Radiotherapy for Cerebral Low-Grade Glioma in the Adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council Study BR04: An Interim Analysis
Prognostic Value of Initial Magnetic Resonance Imaging Growth Rates for World Health Organization Grade II Glioma